ArticleCancer & metabolism2020

Metabolic plasticity imparts erlotinib-resistance in pancreatic cancer by upregulating glucose-6-phosphate dehydrogenase.

Neha Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.